RAT PHI, PHI-GLY AND PHV(1-42) STIMULATE ADENYLATE-CYCLASE IN 6 RAT-TISSUE AND CELL-MEMBRANES

被引:14
作者
CAUVIN, A [1 ]
VANDERMEERSPIRET, MC [1 ]
VANDERMEERS, A [1 ]
COUSSAERT, E [1 ]
DENEEF, P [1 ]
ROBBERECHT, P [1 ]
CHRISTOPHE, J [1 ]
机构
[1] UNIV LIBRE BRUXELLES,SCH MED,DEPT BIOCHEM & NUTR,BLVD WATERLOO 115,B-1000 BRUSSELS,BELGIUM
关键词
Adenylate cyclase; Anterior pituitary; Exocrine pancreas; Liver; Lung; Lymphocytes; PHI; PHI-GLY and PHV(1-42) receptors; Thymocyte cell line 51E;
D O I
10.1016/0196-9781(90)90025-Z
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
PHI and the two C-terminally extended forms PHI-GLY and PHV(1-42) coexist in rat tissues. We compared the relative potency and efficacy of these three PHI forms and of VIP to stimulate adenylate cyclase activity and, when feasible, to occupy VIP receptors in six rat tissue and cell membranes. With the exception of lung membranes, all three PHI forms were markedly less potent than VIP but all were systematically as efficacious. PHI-GLY and PHV(1-42) were never more potent than PHI itself and their relative potencies revealed four spectra, depending on the membrane preparation tested: 1) PHI = PHI-GLY = PHV(1-42) in hepatic, pulmonary and pancreatic membranes; 2) PHI > PHV(1-42) = PHI-GLY in membranes from circulating lymphocytes; 3) PHI = PHV(1-42) > PHI-GLY in membranes from the thymocyte cell line 51E; and 4) PHI > PHI-GLY = PHV(1-42) in anterior pituitary membranes. These results indicate that the two naturally observed C-terminal extensions of rat PHI variously affected peptide potency on 6 rat membrane preparations. © 1990.
引用
收藏
页码:1009 / 1014
页数:6
相关论文
共 36 条
[1]   PORCINE PEPTIDE HAVING N-TERMINAL HISTIDINE AND C-TERMINAL ISOLEUCINE AMIDE (PHI) - VASOACTIVE INTESTINAL PEPTIDE (VIP) AND SECRETIN-LIKE EFFECTS IN DIFFERENT TISSUES FROM THE RAT [J].
BATAILLE, D ;
GESPACH, C ;
LABURTHE, M ;
AMIRANOFF, B ;
TATEMOTO, K ;
VAUCLIN, N ;
MUTT, V ;
ROSSELIN, G .
FEBS LETTERS, 1980, 114 (02) :240-242
[2]   THE DISTRIBUTIONS OF PHI AND VIP IN PORCINE GUT AND THEIR CO-LOCALIZATION TO A PROPORTION OF INTRINSIC GANGLION-CELLS [J].
BISHOP, AE ;
POLAK, JM ;
YIANGOU, Y ;
CHRISTOFIDES, ND ;
BLOOM, SR .
PEPTIDES, 1984, 5 (02) :255-259
[3]   CLINICAL ASPECTS OF VIP AND RELATED PEPTIDES [J].
BLOOM, SR .
REGULATORY PEPTIDES, 1989, 26 (02) :144-144
[4]   THE MOLECULAR-BASIS OF MUSCARINIC RECEPTOR DIVERSITY [J].
BONNER, TI .
TRENDS IN NEUROSCIENCES, 1989, 12 (04) :148-151
[5]  
BOYUM A, 1968, SCAND J CLIN LAB INV, VS 21, P77
[6]   PEPTIDE HISTIDINE ISOLEUCINAMIDE (PHI)-(1-27)-GLY AS A NEW MAJOR FORM OF PHI IN THE RAT SMALL-INTESTINE [J].
CAUVIN, A ;
VANDERMEERS, A ;
VANDERMEERSPIRET, MC ;
RATHE, J ;
ROBBERECHT, P ;
CHRISTOPHE, J .
ENDOCRINOLOGY, 1989, 125 (03) :1296-1302
[7]   VARIABLE DISTRIBUTION OF 3 MOLECULAR-FORMS OF PEPTIDE HISTIDINE ISOLEUCINAMIDE IN RAT-TISSUES - IDENTIFICATION OF THE LARGE MOLECULAR-FORM AS PEPTIDE HISTIDINE VALINE-(1-42) [J].
CAUVIN, A ;
VANDERMEERS, A ;
VANDERMEERSPIRET, MC ;
ROBBERECHT, P ;
CHRISTOPHE, J .
ENDOCRINOLOGY, 1989, 125 (05) :2645-2655
[8]   DISTRIBUTION OF PEPTIDE HISTIDINE ISOLEUCINE IN THE MAMMALIAN RESPIRATORY-TRACT AND SOME ASPECTS OF ITS PHARMACOLOGY [J].
CHRISTOFIDES, ND ;
YIANGOU, Y ;
PIPER, PJ ;
GHATEI, MA ;
SHEPPARD, MN ;
TATEMOTO, K ;
POLAK, JM ;
BLOOM, SR .
ENDOCRINOLOGY, 1984, 115 (05) :1958-1963
[9]   STUDIES ON THE DISTRIBUTION OF PHI IN MAMMALS [J].
CHRISTOFIDES, ND ;
POLAK, JM ;
BLOOM, SR .
PEPTIDES, 1984, 5 (02) :261-266
[10]  
FAHRENKRUG J, 1989, REGUL PEPTIDES, V26, P155, DOI 10.1016/0167-0115(89)90034-7